Brucellosis natural history, complications and prognosis: Difference between revisions
No edit summary |
m (Bot: Removing from Primary care) |
||
(20 intermediate revisions by 6 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Brucellosis}} | {{Brucellosis}} | ||
{{CMG}}; {{AE}} {{RT}} {{DL}} | {{CMG}}; {{AE}} {{RT}} {{DL}}{{VD}} | ||
==Overview== | ==Overview== | ||
If left untreated, patients with brucellosis may progress to develop focal | If left untreated, patients with [[brucellosis]] may progress to develop focal [[Organ (biology)|organ]] [[complications]], relapses or chronic brucellosis.<ref name="f">Brucellosis. CDC. http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/brucellosis. Accessed on February 3, 2016</ref> Common [[complications]] of brucellosis include [[hepatitis|granulomatous hepatitis]], [[arthritis]], [[sacroiliitis]], [[meningitis]], [[orchitis]], [[epididymitis]] [[uveitis]], and [[endocarditis]]. The [[prognosis]] of brucellosis is good with adequate treatment. | ||
==Natural History== | ==Natural History== | ||
If left untreated, patients with [[brucellosis]] may progress to develop focal [[Organ (anatomy)|organ]] involvement, [[Relapse|relapses]] and chronic [[brucellosis]].<ref name="d">Brucellosis. CDC. http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/brucellosis. Accessed on February 3, 2016</ref> | |||
==Complications== | ==Complications== | ||
Complications of [[brucellosis]] include the following:<ref name="pmid8699960">{{cite journal| author=Colmenero JD, Reguera JM, Martos F, Sánchez-De-Mora D, Delgado M, Causse M et al.| title=Complications associated with Brucella melitensis infection: a study of 530 cases. | journal=Medicine (Baltimore) | year= 1996 | volume= 75 | issue= 4 | pages= 195-211 | pmid=8699960 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8699960 }}</ref><ref name="pmid17901634">{{cite journal| author=Mantur BG, Amarnath SK, Shinde RS| title=Review of clinical and laboratory features of human brucellosis. | journal=Indian J Med Microbiol | year= 2007 | volume= 25 | issue= 3 | pages= 188-202 | pmid=17901634 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17901634 }}</ref><ref name="pmid159304">{{cite journal| author=Overturf ML, Druihet RE, Fitz A| title=The effects of kallikrein, plasmin, and thrombin on hog kidney renin. | journal=J Biol Chem | year= 1979 | volume= 254 | issue= 23 | pages= 12078-83 | pmid=159304 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=159304 }}</ref><ref>Doganay M, Aygen B. Human brucellosis: An overview. Int J Infect Dis 2003; 7:173.</ref><ref name="pmid7546364">{{cite journal| author=Young EJ| title=Brucellosis: current epidemiology, diagnosis, and management. | journal=Curr Clin Top Infect Dis | year= 1995 | volume= 15 | issue= | pages= 115-28 | pmid=7546364 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7546364 }}</ref><ref name="pmid21623056">{{cite journal| author=Zamani A, Kooraki S, Mohazab RA, Zamani N, Matloob R, Hayatbakhsh MR et al.| title=Epidemiological and clinical features of Brucella arthritis in 24 children. | journal=Ann Saudi Med | year= 2011 | volume= 31 | issue= 3 | pages= 270-3 | pmid=21623056 | doi=10.4103/0256-4947.81543 | pmc=3119967 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21623056 }}</ref><ref name="pmid2330811">{{cite journal| author=Mousa AM, Bahar RH, Araj GF, Koshy TS, Muhtaseb SA, al-Mudallal DS et al.| title=Neurological complications of brucella spondylitis. | journal=Acta Neurol Scand | year= 1990 | volume= 81 | issue= 1 | pages= 16-23 | pmid=2330811 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2330811 }}</ref><ref name="pmid13130417">{{cite journal| author=Pappas G, Bosilkovski M, Akritidis N, Mastora M, Krteva L, Tsianos E| title=Brucellosis and the respiratory system. | journal=Clin Infect Dis | year= 2003 | volume= 37 | issue= 7 | pages= e95-9 | pmid=13130417 | doi=10.1086/378125 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13130417 }}</ref><ref name="pmid24480149">{{cite journal| author=Herrick JA, Lederman RJ, Sullivan B, Powers JH, Palmore TN| title=Brucella arteritis: clinical manifestations, treatment, and prognosis. | journal=Lancet Infect Dis | year= 2014 | volume= 14 | issue= 6 | pages= 520-6 | pmid=24480149 | doi=10.1016/S1473-3099(13)70270-6 | pmc=4498663 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24480149 }}</ref> | |||
== | {| class="wikitable" | ||
! colspan="2" |Complications of Brucellosis | |||
|- | |||
|'''Osteoarticular''' | |||
| | |||
*Most frequent complications | *Most frequent complications | ||
*Occur in approximately 40% of cases. | *Occur in approximately 40% of cases. | ||
Line 23: | Line 25: | ||
*[[Tenosynovitis]] | *[[Tenosynovitis]] | ||
*[[Spondylitis]] | *[[Spondylitis]] | ||
|- | |||
|'''[[Cardiovascular]]''' | |||
| | |||
*[[Infective endocarditis]] | *[[Infective endocarditis]] | ||
**Common cardiovascular complication | **Common [[cardiovascular]] complication | ||
**Frequent cause of death | **Frequent cause of death | ||
**It has been reported in approximately 2% of cases | **It has been reported in approximately 2% of cases | ||
Line 32: | Line 35: | ||
**[[Valve]] replacement [[surgery]] is usually needed apart from the medical therapy | **[[Valve]] replacement [[surgery]] is usually needed apart from the medical therapy | ||
*[[Aneurysm of sinus of valsalva]] | *[[Aneurysm of sinus of valsalva]] | ||
**Common complication when [[infection]] is due to ''B. suis'' | **Common complication when [[infection]] is due to ''B.suis'' | ||
|- | |||
|'''[[Hepatobiliary system|Hepatobiliary complications]]''' | |||
| | |||
*[[Granulomatous hepatitis]] | *[[Granulomatous hepatitis]] | ||
**Due to ''[[Brucella abortus|B. abortus]]'' | **Due to ''[[Brucella abortus|B. abortus]]'' | ||
Line 41: | Line 45: | ||
* Chronic suppurative lesions and [[Hepatic abscess|hepatic abscesses]] | * Chronic suppurative lesions and [[Hepatic abscess|hepatic abscesses]] | ||
**Due to B. suis | **Due to B. suis | ||
|- | |||
|'''[[Genitourinary]]''' | |||
|[[Orchitis]] and [[epididymitis]] | |||
*Frequent [[Genitourinary system|genitourinary]] complications within men | |||
|- | |||
|'''[[Neurology|Neurological]]''' | |||
| | |||
*[[Meningitis]] or [[meningoencephalitis]] | *[[Meningitis]] or [[meningoencephalitis]] | ||
**Most common frequent complications of neurobrucellosis | **Most common frequent complications of neurobrucellosis | ||
Line 58: | Line 63: | ||
*[[Neuropathy]]/[[radiculopathy]] | *[[Neuropathy]]/[[radiculopathy]] | ||
*[[Poliomyelitis]]-like syndrome | *[[Poliomyelitis]]-like syndrome | ||
|- | |||
|'''[[Gastrointestinal]]''' | |||
|[[Colitis]], [[ileitis]], and [[spontaneous bacterial peritonitis]]. | |||
*Rare cases have been reported. | |||
|- | |||
|'''[[Respiratory tract]]''' | |||
| | |||
*[[Bronchopneumonia]] | *[[Bronchopneumonia]] | ||
*[[Empyema]] | *[[Empyema]] | ||
Line 70: | Line 76: | ||
*[[Lung nodule|Lung nodules]] | *[[Lung nodule|Lung nodules]] | ||
*[[Pleural effusions]] | *[[Pleural effusions]] | ||
|- | |||
|'''[[Pregnancy]]''' | |||
|[[Spontaneous abortion]] | |||
|- | |||
|'''[[Cutaneous]]''' | |||
| | |||
*[[Erythema nodosum]] | *[[Erythema nodosum]] | ||
*[[Nodules]] | *[[Nodules]] | ||
Line 83: | Line 90: | ||
*[[Abscesses]], cutaneous ulcers, and [[suppurative]] [[lymphangitis]] | *[[Abscesses]], cutaneous ulcers, and [[suppurative]] [[lymphangitis]] | ||
**Common complication when infection is due to ''B. suis'' | **Common complication when infection is due to ''B. suis'' | ||
|- | |||
|'''Opthalmic''' | |||
|[[Uveitis]] | |||
*Most frequent ophtalmic complications<ref name="abc">FAO/WHO/OIE Brucellosis in humans and animals. WHO (2006). http://www.who.int/csr/resources/publications/Brucellosis.pdf Accessed on February 3, 2016 </ref> | |||
|} | |||
==Prognosis== | ==Prognosis== | ||
The [[prognosis]] of [[brucellosis]] is good with treatment. [[Mortality]] is less then 1%, usually due to consequence of [[cardiac]] involvement or severe [[Neurology|neurologic]] disease.<ref>Brucellosis "Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson, Joseph Loscalzo"Harrison's Principles of Internal Medicine, 19e Accessed on December 9th, 2017</ref> | |||
==Reference== | ==Reference== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Pulmonology]] | |||
[[Category:Hepatology]] | |||
[[Category:Rheumatology]] | |||
[[Category:Nephrology]] |
Latest revision as of 20:44, 29 July 2020
Brucellosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Brucellosis natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Brucellosis natural history, complications and prognosis |
FDA on Brucellosis natural history, complications and prognosis |
CDC on Brucellosis natural history, complications and prognosis |
Brucellosis natural history, complications and prognosis in the news |
Blogs on Brucellosis natural history, complications and prognosis |
Risk calculators and risk factors for Brucellosis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Danitza LukacVishal Devarkonda, M.B.B.S[3]
Overview
If left untreated, patients with brucellosis may progress to develop focal organ complications, relapses or chronic brucellosis.[1] Common complications of brucellosis include granulomatous hepatitis, arthritis, sacroiliitis, meningitis, orchitis, epididymitis uveitis, and endocarditis. The prognosis of brucellosis is good with adequate treatment.
Natural History
If left untreated, patients with brucellosis may progress to develop focal organ involvement, relapses and chronic brucellosis.[2]
Complications
Complications of brucellosis include the following:[3][4][5][6][7][8][9][10][11]
Complications of Brucellosis | |
---|---|
Osteoarticular |
|
Cardiovascular |
|
Hepatobiliary complications |
|
Genitourinary | Orchitis and epididymitis
|
Neurological |
|
Gastrointestinal | Colitis, ileitis, and spontaneous bacterial peritonitis.
|
Respiratory tract | |
Pregnancy | Spontaneous abortion |
Cutaneous |
|
Opthalmic | Uveitis
|
Prognosis
The prognosis of brucellosis is good with treatment. Mortality is less then 1%, usually due to consequence of cardiac involvement or severe neurologic disease.[13]
Reference
- ↑ Brucellosis. CDC. http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/brucellosis. Accessed on February 3, 2016
- ↑ Brucellosis. CDC. http://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/brucellosis. Accessed on February 3, 2016
- ↑ Colmenero JD, Reguera JM, Martos F, Sánchez-De-Mora D, Delgado M, Causse M; et al. (1996). "Complications associated with Brucella melitensis infection: a study of 530 cases". Medicine (Baltimore). 75 (4): 195–211. PMID 8699960.
- ↑ Mantur BG, Amarnath SK, Shinde RS (2007). "Review of clinical and laboratory features of human brucellosis". Indian J Med Microbiol. 25 (3): 188–202. PMID 17901634.
- ↑ Overturf ML, Druihet RE, Fitz A (1979). "The effects of kallikrein, plasmin, and thrombin on hog kidney renin". J Biol Chem. 254 (23): 12078–83. PMID 159304.
- ↑ Doganay M, Aygen B. Human brucellosis: An overview. Int J Infect Dis 2003; 7:173.
- ↑ Young EJ (1995). "Brucellosis: current epidemiology, diagnosis, and management". Curr Clin Top Infect Dis. 15: 115–28. PMID 7546364.
- ↑ Zamani A, Kooraki S, Mohazab RA, Zamani N, Matloob R, Hayatbakhsh MR; et al. (2011). "Epidemiological and clinical features of Brucella arthritis in 24 children". Ann Saudi Med. 31 (3): 270–3. doi:10.4103/0256-4947.81543. PMC 3119967. PMID 21623056.
- ↑ Mousa AM, Bahar RH, Araj GF, Koshy TS, Muhtaseb SA, al-Mudallal DS; et al. (1990). "Neurological complications of brucella spondylitis". Acta Neurol Scand. 81 (1): 16–23. PMID 2330811.
- ↑ Pappas G, Bosilkovski M, Akritidis N, Mastora M, Krteva L, Tsianos E (2003). "Brucellosis and the respiratory system". Clin Infect Dis. 37 (7): e95–9. doi:10.1086/378125. PMID 13130417.
- ↑ Herrick JA, Lederman RJ, Sullivan B, Powers JH, Palmore TN (2014). "Brucella arteritis: clinical manifestations, treatment, and prognosis". Lancet Infect Dis. 14 (6): 520–6. doi:10.1016/S1473-3099(13)70270-6. PMC 4498663. PMID 24480149.
- ↑ FAO/WHO/OIE Brucellosis in humans and animals. WHO (2006). http://www.who.int/csr/resources/publications/Brucellosis.pdf Accessed on February 3, 2016
- ↑ Brucellosis "Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson, Joseph Loscalzo"Harrison's Principles of Internal Medicine, 19e Accessed on December 9th, 2017